Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05194787




Registration number
NCT05194787
Ethics application status
Date submitted
29/12/2021
Date registered
18/01/2022

Titles & IDs
Public title
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Scientific title
TAS Test: Determining the Feasibility and Validity of Online Motor-cognitive Testing for Early Detection of Alzheimer's Disease
Secondary ID [1] 0 0
H0021660
Universal Trial Number (UTN)
Trial acronym
TASTest
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Alzheimer Disease 0 0
Dementia 0 0
Age-related Cognitive Decline 0 0
Condition category
Condition code
Neurological 0 0 0 0
Alzheimer's disease
Neurological 0 0 0 0
Dementias
Mental Health 0 0 0 0
Other mental health disorders

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Diagnosis / Prognosis - Cognitive test scores, clinical diagnosis and blood biomarkers

Diagnosis / Prognosis: Cognitive test scores, clinical diagnosis and blood biomarkers
Clinical diagnosis of Alzheimer's disease, mild cognitive impairment or normal ageing.

Cognitive test score on CANTAB Blood biomarker (p-tau 181) level
Intervention code [1] 0 0
Diagnosis / Prognosis
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Develop and validate the optimal TAS Test protocol to detect pre-AD (p-tau 181 positivity)
Timepoint [1] 0 0
3 years
Primary outcome [2] 0 0
Prospectively validate TAS Test to predict risks of cognitive decline
Timepoint [2] 0 0
5 years
Primary outcome [3] 0 0
Prospectively validate TAS Test to predict risks of AD diagnosis
Timepoint [3] 0 0
5 years

Eligibility
Key inclusion criteria
> 50years old
Minimum age
50 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
established diagnosis of dementia

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
5/03/2021
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/12/2030
Actual
Sample size
Target
3000
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
TAS
Recruitment hospital [1] 0 0
University of Tasmania - Hobart
Recruitment postcode(s) [1] 0 0
7001 - Hobart

Funding & Sponsors
Primary sponsor type
Other
Name
University of Tasmania
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
National Health and Medical Research Council, Australia
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
University of Sydney
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
University of Leeds
Address [3] 0 0
Country [3] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Prof Vickers, PhD DSc
Address 0 0
University of Tasmania
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
A/Prof Alty, MD FRACP
Address 0 0
Country 0 0
Phone 0 0
+61 (0)3 36226 4273
Fax 0 0
Email 0 0
Jane.Alty@utas.edu.au
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Undecided
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT05194787